WNK3 and type 2 diabetes mellitus: Meanwhile, we used both the non-selective P1R and P2R antagonists as well as the specific antagonists available against A1R, P2X7R, and P2Y6R to identify the putative PRs that accounts for endothelial dysfunction in T2D.